Add Company
Join Now

Neoclone Biotechnology Revenue and Competitors

License our Company Data API

USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Neoclone Biotechnology's estimated annual revenue is currently $775k per year.(i)
  • Neoclone Biotechnology's estimated revenue per employee is $155,000

Employee Data

  • Neoclone Biotechnology has 5 Employees.(i)
  • Neoclone Biotechnology grew their employee count by -17% last year.

Neoclone Biotechnology's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Director Phage TechnologiesReveal Email/Phone
3
Production ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$9.1M59-9%N/AN/A
#10
$16.6M1073%N/AN/A
Add Company

What Is Neoclone Biotechnology?

NeoClone produces high-quality monoclonal antibody products for the biotechnology and research markets. In addition to generating monoclonals through the traditional fusion technology NeoClone holds exclusive license to the ABL-MYC retroviral transformation system, a technique that produces monoclonal antibodies -- "NeoClone®"-brand or "NeoAb®" antibodies -- in an accelerated time and with cost savings. This allows NeoClone to provide custom antibodies faster and more cost effective.

keywords:N/A

N/A

Total Funding

5

Number of Employees

$775k

Revenue (est)

-17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.1M5-29%$36M
#2
$0.6M5-29%N/A
#3
$0.1M5-29%$12M
#4
$0.5M5-17%$76.7M
#5
$0.4M50%N/A